TapewireFind a company

person · Reporting owner

COOK JEREMY CURNOCK

Disclosed activity across 2 companies

Tapewire entity
41275
SEC CIK
0001216486

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AVITA Medical, Inc.RCEL · Entity 5905DirectorJune 03, 2026June 04, 2026
Armata Pharmaceuticals, Inc.ARMP · Entity 6329DirectorDecember 31, 2019February 14, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AVITA Medical, Inc.

Report date June 03, 2026 · Filed June 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect62,050 Reported balance After 2026-01-20 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-01-20 · Grant · Acquired 22,214 · Balance 62,050

F1: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.

F2: Includes unvested RSUs.

Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.77 · Expires 2036-01-20Direct16,133 Reported balance After 2026-01-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-01-20 · Grant · Acquired 16,133 · Balance 16,133

F3: On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.

F2: Includes unvested RSUs.

F3: On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.

Armata Pharmaceuticals, Inc.

Report date December 31, 2019 · Filed February 14, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Warrant to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.32 · Expires 2021-11-22IndirectSee Footnote0 Reported balance After 2019-05-09 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2019-05-09 · Other · Disposed 46,666 · Balance 0

F4: Price reported is reflective of adjustments made after the date of issuance pursuant the terms of the warrant.

F1: The reported securities were redeemed by the issuer for $12,065.46.

F2: The number of shares of common stock for which the warrant was exercisable does not reflect the 1-for-14 reverse stock split that was effected on May 9, 2019.

F3: The warrant was held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities were redeemed by the issuer for $12,065.46.

F2: The number of shares of common stock for which the warrant was exercisable does not reflect the 1-for-14 reverse stock split that was effected on May 9, 2019.

F3: The warrant was held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

F4: Price reported is reflective of adjustments made after the date of issuance pursuant the terms of the warrant.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 20, 2026 Filed Jun 4, 2026 23:09 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantStock Options (Right to Buy) · Derivative 16,133 $0.00 Strike: $3.77 $0.00
Disclosure

SEC source: 0001216486-26-000002 · ownership.xml · derivative · entry 2

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,133

Underlying: Common Stock · 16,133 shares

Expires 2036-01-20

F3 · derivative.exercise_price: On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.

Read SEC document
January 20, 2026 Filed Jun 4, 2026 23:09 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantCommon Stock 22,214 Not disclosed Not disclosed
Disclosure

SEC source: 0001216486-26-000002 · ownership.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,050

F1 · price: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
January 21, 2025 Filed Jun 5, 2025 20:46 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantStock Options (Right to Buy) · Derivative 4,295 $0.00 Strike: $8.73 $0.00
Disclosure

SEC source: 0000950170-25-082428 · ownership.xml · derivative · entry 2

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,295

Underlying: Common Stock · 4,295 shares

Expires 2035-01-21

F3 · derivative.exercise_price: On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025.

Read SEC document
January 21, 2025 Filed Jun 5, 2025 20:46 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantCommon Stock 10,022 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-082428 · ownership.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,836

F1 · price: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
June 05, 2024 Filed Jun 6, 2024 23:29 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantStock Options (Right to Buy) · Derivative 3,943 $0.00 Strike: $9.51 $0.00
Disclosure

SEC source: 0000950170-24-070114 · ownership.xml · derivative · entry 2

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,943

Underlying: Common Stock · 3,943 shares

Expires 2034-06-05

Read SEC document
June 05, 2024 Filed Jun 6, 2024 23:29 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantCommon Stock 9,200 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-070114 · ownership.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,814

F1 · price: Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
December 21, 2023 Filed Dec 22, 2023 22:01 UTC Amendment AVITA Medical, Inc. RCEL · Entity 5905 SaleCommon 2,500 $12.49 $31,225.00
Disclosure

SEC source: 0000950170-23-072730 · ownership.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,614

F1 · shares: Shares sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs

F2 · shares: The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction.

F2 · price: The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $12.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4.

F2 · balance_after: The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction.

F4 · balance_after: Includes unvested RSUs

Read SEC document
December 13, 2023 Filed Dec 14, 2023 22:01 UTC AVITA Medical, Inc. RCEL · Entity 5905 SaleCommon 2,518 $12.27 $30,895.86
Disclosure

SEC source: 0000950170-23-070445 · ownership.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,596

F1 · shares: Shares only sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs

F1 · price: Shares only sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs

F2 · balance_after: Includes unvested RSUs

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:32 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantStock Options (Right to Buy) · Derivative 2,646 $0.00 Strike: $14.17 $0.00
Disclosure

SEC source: 0001209191-23-035428 · doc4.xml · derivative · entry 2

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,646

Underlying: Common Stock · 2,646 shares

Expires 2033-06-06

F1 · shares: The reporting person may elect to acquire the Issuer's CHESS Depositary Interests ("CDIs") in place of common stock upon vesting of a Restricted Stock Unit ("RSU") or exercise of a Stock Option. CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of common stock and have all the rights and privileges of common stock.

F4 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:32 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantCommon Stock 6,175 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035428 · doc4.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,114

F1 · shares: The reporting person may elect to acquire the Issuer's CHESS Depositary Interests ("CDIs") in place of common stock upon vesting of a Restricted Stock Unit ("RSU") or exercise of a Stock Option. CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of common stock and have all the rights and privileges of common stock.

F2 · price: Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

F3 · balance_after: Includes unvested RSUs.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 22:22 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantStock Options (Right to Buy) · Derivative 5,395 $0.00 Strike: $6.95 $0.00
Disclosure

SEC source: 0001209191-22-061279 · doc4.xml · derivative · entry 2

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,395

Underlying: Common Stock · 5,395 shares

Expires 2032-12-12

F3 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 22:22 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantCommon Stock 12,589 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-061279 · doc4.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,939

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantStock Options (Right to Buy) · Derivative 2,550 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071255 · doc4.xml · derivative · entry 2

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,550

Underlying: Common Stock · 2,550 shares

Expires 2031-12-22

F3 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC AVITA Medical, Inc. RCEL · Entity 5905 GrantCommon Stock 4,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071255 · doc4.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,350

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
May 22, 2019 Filed May 25, 2019 01:30 UTC Armata Pharmaceuticals, Inc. ARMP · Entity 6329 GrantStock Option (Right to Buy) · Derivative 27,383 $0.00 Strike: $3.15 $0.00
Disclosure

SEC source: 0001144204-19-028262 · tv522369_4.xml · derivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,383

Underlying: Common Stock · 27,383 shares

Expires 2029-05-22

F1 · derivative.exercise_date: The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each annual anniversary of the date of grant.

Read SEC document
May 09, 2019 Filed Feb 14, 2020 23:00 UTC Armata Pharmaceuticals, Inc. ARMP · Entity 6329 OtherWarrant to Purchase Common Stock · Derivative 46,666 $12,065.46 Strike: $0.32 $563,046,756.36
Disclosure

SEC source: 0001104659-20-022092 · tm208184-5_form5.xml · derivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 46,666 shares

Expires 2021-11-22

F4 · derivative.exercise_price: Price reported is reflective of adjustments made after the date of issuance pursuant the terms of the warrant.

F1 · kind: The reported securities were redeemed by the issuer for $12,065.46.

F2 · derivative.underlying_shares: The number of shares of common stock for which the warrant was exercisable does not reflect the 1-for-14 reverse stock split that was effected on May 9, 2019.

F3 · ownership.nature: The warrant was held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

Read SEC document
March 22, 2018 Filed Mar 27, 2018 00:50 UTC Armata Pharmaceuticals, Inc. APHB · Entity 6329 PurchaseCommon Stock 181,820 $1.10 $200,002.00
Disclosure

SEC source: 0001209191-18-021678 · doc4.xml · nonDerivative · entry 5

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 411,105

F2 · ownership.nature: The shares are held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 19, 2017 Filed Mar 27, 2018 00:50 UTC Armata Pharmaceuticals, Inc. APHB · Entity 6329 PurchaseCommon Stock 105,015 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-021678 · doc4.xml · nonDerivative · entry 4

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 229,285

F1 · price: The Shares were issued pursuant to a Common Stock Issuance Agreement, dated April 8, 2016, between the Issuer and certain holders of the Issuer's Series B Preferred Stock (the "Holders"), as amended. As consideration for the Shares, among other things, the Holders waived their right to receive certain cash payments to which they were entitled upon the conversion of their Series B Preferred Stock and also waived certain registration rights relating to certain future registration statements or public offerings that may be filed or conducted by the Issuer.

F2 · ownership.nature: The shares are held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 07, 2017 Filed Sep 12, 2017 00:19 UTC Armata Pharmaceuticals, Inc. APHB · Entity 6329 GrantStock Option (Right to Buy) · Derivative 10,900 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-17-052310 · doc4.xml · derivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,900

Underlying: Common Stock · 10,900 shares

Expires 2027-09-06

Read SEC document
June 29, 2017 Filed Mar 27, 2018 00:50 UTC Armata Pharmaceuticals, Inc. APHB · Entity 6329 PurchaseCommon Stock 5,757 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-021678 · doc4.xml · nonDerivative · entry 3

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 124,270

F1 · price: The Shares were issued pursuant to a Common Stock Issuance Agreement, dated April 8, 2016, between the Issuer and certain holders of the Issuer's Series B Preferred Stock (the "Holders"), as amended. As consideration for the Shares, among other things, the Holders waived their right to receive certain cash payments to which they were entitled upon the conversion of their Series B Preferred Stock and also waived certain registration rights relating to certain future registration statements or public offerings that may be filed or conducted by the Issuer.

F2 · ownership.nature: The shares are held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

Read SEC document
November 22, 2016 Filed Mar 27, 2018 00:50 UTC Armata Pharmaceuticals, Inc. APHB · Entity 6329 PurchaseWarrant to Purchase Common Stock · Derivative 46,666 $0.10 Strike: $0.57 $4,666.60
Disclosure

SEC source: 0001209191-18-021678 · doc4.xml · derivative · entry 7

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 46,666

Underlying: Common Stock · 46,666 shares

Expires 2021-11-22

F3 · derivative.exercise_price: Price reported is reflective of adjustments made to the exercise price after the date of issuance pursuant to the terms of the warrant.

F4 · derivative.exercise_date: Immediately exercisable.

F5 · ownership.nature: The warrant is held by One Funds Management. The Reporting Person may be deemed to have shared voting and dispositive power over the securities beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

Read SEC document
November 22, 2016 Filed Mar 27, 2018 00:50 UTC Armata Pharmaceuticals, Inc. APHB · Entity 6329 PurchaseCommon Stock 46,666 $7.40 $345,328.40
Disclosure

SEC source: 0001209191-18-021678 · doc4.xml · nonDerivative · entry 2

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 118,513

F2 · ownership.nature: The shares are held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

Read SEC document
June 21, 2016 Filed Mar 27, 2018 00:50 UTC Armata Pharmaceuticals, Inc. APHB · Entity 6329 PurchaseCommon Stock 15,057 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-021678 · doc4.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 71,847

F1 · price: The Shares were issued pursuant to a Common Stock Issuance Agreement, dated April 8, 2016, between the Issuer and certain holders of the Issuer's Series B Preferred Stock (the "Holders"), as amended. As consideration for the Shares, among other things, the Holders waived their right to receive certain cash payments to which they were entitled upon the conversion of their Series B Preferred Stock and also waived certain registration rights relating to certain future registration statements or public offerings that may be filed or conducted by the Issuer.

F2 · ownership.nature: The shares are held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.